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Abstract 
Metabolic Syndrome (MetS) is a cluster of metabolic abnormalities known to increase heart 
disease  risk  by  two-fold  and  type  2  diabetes  risk  by  five-fold.  These  disturbances  include 
dyslipidemias, hypertension, hyperglycemia and central adiposity in addition to insulin resistance 
and low grade inflammation. The prevalence of MetS is about 34% in the United States with 
variations according to ethnicity and race. Lfestyle factors including smoking, lack of exercise, 
poor dietary habits as well as low socioeconomic status are associated with the development of 
MetS. Diet is considered one of the major contributors to MetS. Adherence to the Mediterranean 
diet (high intake of whole grains, fruits and vegetables, olive oil, fish, low-fat dairy products, and 
moderate wine consumption) has been associated with lower prevalence of MetS. Interventions 
utilizing this dietary approach have proven to be successful in reducing some of the associated 
metabolic  abnormalities.  In  this  review,  evidence  from  epidemiological  and  clinical  studies 
showing  the  benefits  of  the  Mediterranean  diet  is  presented.  The  effect  of  the  specific 
components of the Mediterranean diet is also discussed.  
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Introduction 
Overweight and obesity trends have substantially increased in alarming proportions in the last 40 
years. Using the 1976-2008 National Health Interview Services, Singh et al. [i] reported that the 
prevalence of overall overweight increased from 36.9 to 62%, among which the prevalence of 
obesity increased from 8.7 to 27.4%. As it is well established that overweight/obese individuals 
have  a  higher  risk  of  developing  insulin  resistance,  metabolic  syndrome  (MetS),  diabetes, 
hypertension  and  coronary  heart  disease  (CHD)  [ii],  there  is  a  great  need  for  prevention 
programs prescribing healthy diets and promoting exercise. 
MetS encompasses a cluster of symptoms including dyslipidemias, central obesity, high 
fasting glucose and hypertension. These factors are associated with increased risk for both type-2 
diabetes mellitus (T2DM) and CHD [iii]. The latest consensus on the definition of the MetS is as 
follows: Waist circumference (WC) ≥102 cm for men and ≥ 88 cm for women; triglycerides 
(TG) ≥ 150 mg/dL (1.69 mmol/L); HDL ≤ 40 mg/dL (1.04 mmol/L) for men and ≤ 50 mg/dL 
(1.29 mmol/L) for women; blood pressure ≥ 130/85 mm Hg; and fasting glucose ≥ 100 mg/dL 
(5.55 mmol/L). When 3 out of 5 identified characteristics are present, a diagnosis of MetS is 
made [iv].  
  Central obesity or increased WC is a key determinant in the development of MetS. While 
abdominal obesity is determined by accumulation of both subcutaneous and visceral adipose 
tissue, the latter appears to play a major role in the metabolic irregularities that characterize MetS 
[v].  Insulin resistance and many of its related features could arise from trunk fat delivering free 
fatty acids (FFA) at a high rate to the liver via the portal vein. This effect in turn increases 
hepatic  glucose  production,  reduces  hepatic  insulin  clearance,  and  finally  leads  to  insulin 
resistance,  hyperinsulinemia  and  hyperglycemia  [vi].  MetS  is  also  characterized  by  a  pro-
inflammatory  state  and  oxidative  stress,  which  further  increases  CHD  risk  [vii].  Pro-
inflammatory cytokines, such as C-reactive protein, interleukin (IL)-6 and tumor necrosis factor-
alpha  (TNF-α),  can  also  promote  insulin  resistance  and  impaired  glucose  tolerance,  and 
accelerate the development of MetS and T2DM [viii]. 
Changes in macronutrient composition such as carbohydrate restriction [ix] have been 
shown  to  substantially  decrease  central  adiposity  in  subjects  with  MetS.  Other  dietary 
interventions using low glycemic-load diets [x] or low-fat diets [xi] have also been effective in 
reducing  WC  and  central  adiposity.    Diets  high  in  antioxidants  including  polyphenols  [xii], 
carotenoids [xiii] and minerals such as selenium [xiv] have been useful in reducing inflammation 
and  oxidative  stress.  Results  from  these  studies  [9-14]  indicate  that  both  macronutrient Functional Foods in Health and Disease, 2011, 2:25-38  Page 27 of 37 
composition  and  antioxidants  present  in  food  are  quite  effective  in  reducing  the  metabolic 
abnormalities that are associated with MetS. 
The  Mediterranean-style  dietary  pattern,  characterized  by  increased  consumption  of 
whole grains, fruit, vegetables, nuts, N-3 fatty acids and olive oil, has been shown to protect 
against MetS [xv]. In this review, evidence from epidemiological and clinical studies showing 
the  benefits  of  the  Mediterranean  diet  (MedD)  is  presented.  The  effect  of  the  specific 
components of the MedD is also discussed. 
 
Epidemiological data 
Epidemiological analyses of association between adherence to the MedD and prevalence of MetS 
have  been  conducted  in  different  populations.  Evaluation  of  the  SUN  cohort,  consisting  of 
graduate  students  from  Universidad  de  Navarra  who  were  followed  for  6  years,  found  that 
participants with the highest adherence to the MedD exhibited the lowest levels of all risk factors 
of  MetS  [xvi].  Another  study  conducted  among  obese  Greek  individuals  concluded  that 
adherence to the MedD was associated with decreased prevalence of MetS [
xvii]. Similarly Babio 
et al [
xviii], in a cross-sectional study with 808 high cardiovascular risk patients, reported that the 
group with the highest adherence to the MedD had the lowest odds ratios of having MetS (0.44, 
95% CI 0.2 – 0.7) compared to those with the lowest adherence.   
A cross-sectional study from individuals participating in the Canarian Nutrition Survey 
(ENCA)  demonstrated  that  highest  adherence  to  MedD  was  associated  with  lower  blood 
pressure, although there was also a higher prevalence of hyperglycemia [xix]. Other reported 
associations between dietary patterns and risk variables included moderate alcohol intake and 
high  HDL  in  men,  fruit  intake  protecting  against  hypertriglyceridemia,  and  dairy  product 
consumption inversely associated with hyperglycemia [19]. In contrast, a multicenter study of 
the Mediterranean  group concluded that  prevalence of MetS was  not  related to  MedD [xx]. 
Overall, results from the ENCA study are controversial and do not present a clear benefit of high 
adherence  to  MedD  in  lowering  prevalence  of  MetS.  The  ATTICA  study,  a  national  health 
survey based on 2282 Greek adults, reported that 19.8% of subjects had MetS [xxi]. Although 
the odds ratio of having MetS among individuals consuming the MedD was 0.81, high levels of 
inflammatory markers in this population could not be explained by the choice of diet [xxi]. 
Rumawas et al. [xv] evaluated the effects of MedD pattern in mitigating the risk factors 
for T2DM and CHD in the Framingham offspring cohort. Higher adherence to this diet was 
associated with lower WC, fasting plasma glucose, TG, and high HDL, indicating that this type 
of  diet  modifies  all  parameters  of  MetS.    Further,  the  consumption  of  the  MedD  has  been 
evaluated in patients diagnosed with heart disease [xxii], those with T2DM [xxiii], and those 
receiving renal transplantation [xxiv]. In these three studies, adherence to the MedD has been 
associated with reduced risk of MetS. 
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Clinical trials 
Effects on parameters of MetS 
Several recent clinical trials demonstrated that following a MedD resulted in the improvement of 
one or more characteristics of MetS. Esposito et al. [xxv] compared two different interventions, a 
MedD (n = 90) and a prudent diet (n = 90). After 2 years, 40 patients in the intervention group 
had MetS compared to 78 in the control group (P < 0.001), indicating a greater net resolution of 
MetS  when  consuming  MedD.  Lerman  et  al.  [xxvi]  recruited  49  subjects  with  MetS  and 
hypercholesterolemia who were prescribed to consume a low-glycemic-load Mediterranean style  
diet for 12 weeks. Subjects were randomized to diet alone or diet supplemented with specific 
phytochemicals. At end of study, 22% of subjects consuming the diet alone and 43% of those 
receiving the additional phytochemicals had a net resolution of MetS, and the latter had greater 
reductions in their dyslipidemias. Estruch et al [xxvii] recruited 72 individuals and assigned them 
to 3 different groups: low-fat diet (n=257), MedD plus olive oil (n= 257), or MedD plus nuts 
(n=258).  The  authors  concluded  that  the  MedD  was  more  effective  than  the  low-fat  diet  in 
reducing the parameters associated with MetS and inflammation. In the PREDIMED randomized 
trial of high risk individuals, researchers reported that enriching the MedD with nuts was more 
effective in reducing abdominal obesity, decreasing plasma TG and improving blood pressure 
[xxviii].  
Other studies have also reported improvement on all MetS parameters after following a 
MedD for 12 weeks [xxix]. In contrast, in a study of individuals with already established and 
treated  CHD  who  adopted  a  MedD  over  1  year,  the  diet  had  no  effect  on  markers  of 
inflammation  or  other metabolic  risk  factors  [xxx].  In  another  study  in  which  subjects  with 
abdominal obesity were prescribed a MedD for 2 months [xxxi], those under diet supervision (to 
ensure adherence to MedD) exhibited improved endothelial function and greater reductions in 
blood pressure [xxxi].  
 
Effects on inflammatory markers 
In a study of 220 healthy women from Greece, significant associations were found between the 
adiponectin levels and the consumption of whole grain, low-fat dairy, and reduced intake of 
refined cereals, three components of the MedD [32]. Hermsdorff et al. [xxxii] evaluated the 
effects  of  a  hypocaloric  MedD  diet  on  plasma  concentrations  of  retinol  binding  protein-4 
(RBP4), TNF-α and IL-6. Individuals who had greater adherence to the diet exhibited significant 
reductions in these markers of inflammation. A study using a MedD with a low glycemic load 
also demonstrated a reduction in inflammation and insulin resistance after 12 weeks [xxxiii].  
Overall, these results suggest the efficacy of MedD in healthy populations [25-29, 31-34]. A 
summary of these studies is presented in Table 1. 
 
Table 1.  Results from clinical studies using Mediterranean diets (MedD) on the parameters 
of metabolic syndrome and inflammation
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Subjects   Design  Time  Results  Ref 
180 
Individuals 
Randomized, Parallel:  
90 MedD 
90 Prudent Diet 
2y 
 
78 individuals in MedD no 
longer had MetS 
40 Individuals from Prudent 
Diet 
25 
44 Individuals  Randomized, Parallel 
:  
9 MedD only 
25 MedD + 
Phytochemicals 
3 mo  22% of subjects in MedD only 
had resolution of MetS 
43% subjects in MedD + 
phytochemicals had resolution 
of MetS 
26 
772 
Symptomatic 
subjects 
Randomized, Parallel: 
257 Low fat 
257 MedD + olive oil 
257MedD + Nuts 
1 y  Significant differences in 
MedD compared to low fat 
diet. MedD favorably affected 
all parameters of MetS 
27 
1224 Subjects 
with CVD risk 
(61.4% with 
MetS) 
Randomized Parallel: 
Low fat, MedD+ 
olive oil and 
MedD+Nuts  
1y  Resolution of MetS was 2.9% 
for low fat 
6.7% for MedD+ olive oil and 
13.7% MedD + nuts 
28 
101 Patients with 
established heart 
disease 
Randomized, parallel 
48 MedD 
53 Control 
1 year  No changes in plasma lipids or 
inflammatory markers 
30 
90 Subjects with 
abdominal 
obesity 
Randomized, Parallel 
MedD only 
MedD with close 
supervision 
2 mo  Reductions in diastolic blood 
pressure and improvement in 
endothelial function in MedD 
group with supervision 
31 
41 Subjects 
24F/17M 
Hypocaloric MedD  8wk  Significant reductions in 
inflammatory markers 
33 
89 Overweight 
women with 
MetS 
Randomized, parallel: 
44 MedD only 
45 MedD + Medical 
food 
  All Subjects independent of 
treatment had significant 
decreases in inflammatory 
markers 
34 
1   None of these studies included caloric restriction except for reference 33. 
 
 
Individual components of MedD and their effects on parameters of MetS Functional Foods in Health and Disease, 2011, 2:25-38  Page 30 of 37 
The multiple beneficial effects of the MedD on the parameters of MetS are closely associated 
with its individual dietary components. The effects of these components on WC, BP, TG, HDL 
and fasting glucose are summarized in Figure 1. 
 
Figure 1.  Effects of the Mediterranean diet on the parameters of metabolic syndrome (MetS). Central 
obesity is on the axis of MetS leading to increased waist circumference (1. WC). Free fatty acids (FFA) 
are released into circulation from adipose tissue to liver, muscle and pancreas. In the liver, they result in 
increased production of VLDL associated with elevated plasma triglycerides (2. TG) and low HDL (3. 
HDL).  In the pancreas, there is apoptosis and cell death that will result in increases in plasma glucose (4. 
Glucose).  In  the  muscle,  FFA  lead  to  insulin  resistance  and  increased  blood  pressure  (5.  BP).  In 
parentheses  next  to  each  of  the  MetS  characteristics  are  some  of  the  nutrients  or  food  items  from 
Mediterranean diet that have been shown to correct that metabolic abnormality. 
 Functional Foods in Health and Disease, 2011, 2:25-38  Page 31 of 37 
N-3  fatty  acids  or  fish  consumption.  It  is  well  established  that  intake  of  N-3  fatty  acids, 
especially  in  the  form  of  fish  oil,  results  in  decreases  in  plasma  TG  [xxxiv].  The  main 
mechanisms  involved  are  decreased  hepatic  TG  synthesis  and  faster  removal  from  plasma 
[xxxv]. Consumption of fish oil has  also  been associated with  decreases  in  CHD due to its 
known effects in preventing arrhythmias, decreasing platelet aggregation, and lowering heart rate 
[xxxv]. Further, fish oil has been shown to decrease blood pressure [xxxiv].  
 
Olive oil. Olive oil is one of the most representative food items of the traditional MedD. A recent 
review demonstrated its beneficial effects on lowering blood pressure, reducing plasma glucose, 
and improving the cholesterol/HDL ratio and endothelial function [xxxvi]. In a study in which 
MetS patients  consumed virgin  olive oil  and provided blood  samples,  the researchers  found 
repressed expression of pro-inflammatory genes in the mononuclear cells [xxxvii]. This suggests 
that  the  anti-inflammatory  effects  associate  with  MedD  could  partially  be  attributed  to  this 
dietary constituent.  
 
Low-fat  dairy.  Epidemiological  data  suggest  a  strong  link  between  dairy  consumption  and 
decreased insulin resistance and incidence of T2DM. The Prospective Coronary Artery Risk 
Development in Young Adults study reported a 21% decrease in insulin resistance with each 
daily serving of low-fat dairy products [xxxviii]. The beneficial effects may be associated with 
several  of  the  nutrient  components  including  calcium,  magnesium,  potassium,  and  certain 
protein-derived  peptides  with  hypotensive  properties  [xxxix].  Low-fat  dairy  has  also  been 
reported to have an influence on waist circumference in women [xl]. 
 
Low  glycemic  index  and  increased  protein  intake.  The  MedD  is  characterized  by  daily 
consumption of whole grains and high intake of complex carbohydrates and dietary fiber, mainly 
from  fruits  and  vegetables  [xli].  Studies  have  shown  that  decreasing  intakes  of  refined 
carbohydrate [ix] or reducing the glycemic index of a diet [xxix] can reduce central obesity. 
 
Moderate  wine  consumption.  Moderate  wine  consumption  may  be  one  of  the  few  dietary 
interventions known to raise plasma HDL. It has been associated with a lower prevalence of 
MetS, T2DM and CHD [xlii].  Koppes et al. [xliii] investigated cross-sectional and longitudinal 
relationships  between  alcohol  consumption  and  HDL  and  reported  a  positive  significant 
relationship at moderate consumptions. Moderate wine consumption has also been associated 
with down-regulation of adhesion molecules and other inflammatory biomarkers, which may 
explain its role in decreasing the risk for CHD [xliv]. 
 
Whole  grains.  High  intake  of  whole  grains  has  been  related  to  lower  plasma  glucose  and 
improved insulin sensitivity in healthy individuals and in T2DM patients. Data from the Nurses’ 
Health Study also document the importance of whole grain intake as a means to help prevent Functional Foods in Health and Disease, 2011, 2:25-38  Page 32 of 37 
T2DM [xlv].  A recent review proposed that, in addition to the well known constituents of whole 
grains that protect against heart disease and diabetes, whole grains are also a rich source of 
methyl donors and lipotropes that may be involved in lipid metabolism and DNA methylation 
[xlvi].    Weickert  and  Pfeiffer  [xlvii]  emphasized  the  emerging  knowledge  in  the  effects  of 
insoluble fiber derived from whole grains in increasing insulin sensitivity, modulating secretion 
of gut  hormones,  and decreasing inflammation. Consumption of whole grains  has  also  been 
associated with increases in adiponectin [xxxii].  
 
Fruits and vegetables. Fruits and vegetables are excellent sources of fiber and key vitamins and 
minerals.  Due  to  their  high  content  in  antioxidants,  increased  consumption  of  fruits  and 
vegetables  has  been  associated  with  decreased  concentrations  of  C-reactive  protein  and 
homocysteine [xlviii], thus exerting a protective effect against CHD and T2DM.  Polyphenols 
and flavonoids present in fruits and vegetables have also been shown to decrease plasma TG 
[xlix] and blood pressure [l].  
 
Nuts.  Nuts  have  been  shown  to  have  multiple  health  benefits,  including  decreasing  plasma 
cholesterol and TG, ameliorating hypertension, and contributing to decreases in WC [19]. There 
is also strong evidence of nuts protecting against CHD based on their effect in lowering LDL [li]. 
In  addition,  nuts  have the potential to  control  hyperglycemia  as  they  diminish  the glycemic 
response  to  food  [lii].  Further,  reductions  in  oxidation  have  been  observed  in  subjects  who 
consumed 30 g/d of nuts for 12 weeks [liii].  
 
Conclusion 
With  its  macronutrient  composition  and  the  presence  of  antioxidants,  N-3  fatty  acids  and 
moderate  alcohol,  the  Mediterranean  diet  appears  to  be  effective  in  decreasing  metabolic 
abnormalities  associated  with  MetS,  including  central  obesity,  dyslipidemias,  hypertension, 
hyperglycemia, and inflammation. Epidemiological data suggest that individuals following this 
type of diet are at decreased risk for MetS and the associated complications of T2DM and CHD. 
Further,  recent  clinical  trials  in  healthy  individuals  and  those  diagnosed  with  heart  disease, 
diabetes or renal failure appear to benefit from adhering to Mediterranean style diets.  
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